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Yang Li†, Xinying Wang†, Ning Li and Jieshou Li*Abstract
Background: N-3 PUFAs have been demonstrated in vitro it could prevent the intestinal tight junctions (TJs) from
the ischemia/re-perfusion injury and the inflammatory reaction injury. The purpose of this study was to evaluate the
protection of n-3 PUFAs on the intestinal TJs in the rat model of hemorrhagic shock followed by resuscitation.
Methods: Male SD rats (n = 72; 250 ~ 300 g) were randomly divided into 6 groups: SHAM, hemorrhagic shock (HS),
hemorrhagic shock/resuscitation (HS/R), ω-6 group, ω-3 group and ω-3 treatment group. Shock was induced, and
a mean arterial pressure was maintained at 35 to 40 mmHg for 60 minutes. Resuscitation was carried out by
returning half of the shed blood and Ringer’s lactate solution. In ω-6 and ω-3 group, Intralipid or fish oil (0.2 g/Kg),
respectively, was infused 30 minutes after shock. And fish oil was infused with resuscitation in ω-3 treatment group.
Half of each group was killed at 30 minutes and 4 hours after resuscitation, respectively. The serum samples and
the intestinal sample was collected for further examination.
Result: There is no difference between ω-3, ω-3 treatment and sham group in Chiu’s score, but the other three
groups have higher scores than they did. Compared with HS, HSR and ω-6 group, ω-3 and ω-3 treatment group
showed most intact in intestinal mucoscal villi and TJs through HE, SEM and LSCM. The levels of IL-6 and TNF-α of
bowel tissue in ω-3 and ω-3 treatment group were significantly lower than HS and HSR groups’. At the time point
of 30 min, the levels of serum endotoxin were dramatically higher in HS、HSR and ω-6 groups when compared
with ω-3, ω-3 treatment and sham group. However, it in ω-3 group was greater than sham and HS group until 4
hours.
Conclusion: Fish oil pretreatment before resuscitation showed a beneficial effect to the intestinal TJs and
atteunated inflammation after H/R in HS/R rat model and is better than ω-6 PUFAs did.
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Hemorrhagic shock, an independent risk factor for
multiple-organ dysfunction syndrome (MODS) [1], is the
leading cause of death in traumatic patients. It followed by
resuscitation is considered as an insult frequently induces
a systemic inflammatory response syndrome (SIRS) that
results in MODS, which is a major clinical problem. The
concept has developed that the intestinal injury/resuscita-
tion (I/R) injury associated with hemorrhagic shock (HS)
followed by fluid resuscitation is responsible for the failure
of the intestinal barrier, bacterial translocation, systemic
sepsis, and even MODS [2]. Meanwhile, tight junctions* Correspondence: xiaoran8210@gmail.com
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unless otherwise stated.(Tjs), serve as a fence between two cells, play a major role
in this mechanism. Hypoperfusion or ischemia can cause
disruption of the Tjs, with subsequent barrier failure. The
loss of intestinal cell integrity leads to paracellular leakage
of microbial products [3-6].
The influence of the n-3 polyunsaturated fatty acids
(n-3 PUFAs) on inflammatory bowel disease indicated
50% reduction in steroid use and improved histology [7],
delayed relapse [8], reduced disease activity and drugs
usage [4]. Also, the influence of the n-3 fatty acids on
patients under surgical stress indicated reduced wound
and major infections, reduced intra-abdominal abscess
and multiple organ failure, and shortened hospital stay
in several prospective randomized studies in burn,
trauma and major surgery patients. The benefit of n-his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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creatitis, trauma and septic shock. However, the effect of
the n-3PUFAs on intestinal permeability in hemorrhagic
shock/resuscitation (HS/R) is rarely reported [9].
So we make a hypothesis that intravenous n-3 PUFAs
would improve intestinal barrier function in a rat model
of hemorrhagic shock with resuscitation.
Result
Characteristics and shock preparation of rats
All animals survived from shock and completed resuscita-
tion in the four groups. Among the groups, there was no
difference in the change of blood pressure into baseline
following shock and resuscitation (Table 1). Except for the
sham group, all animals were maintained at 35 to 40 mm
Hg for 60 minutes by periodic withdrawal or return of
blood. There were no detectable differences between the
four groups in terms of body weight, cannulation time, or
amount of blood withdrawn.
I-FABP and endotoxin in plasma
HS/R group has the highest concentration of intestinal
fatty acid binding protein (I-FABP) in all the groups.
30 min and 4 hours after resuscitation, the levels of I-
FABP in ω-3 group and ω-3 treatment group had little
change compared with sham group, but they were sig-
nificantly lower than HS, HS/R and ω-6 group (p < 0.05).
(Figure 1A, B)
30 min after resuscitation, the levels of endotoxin in
ω-3 group and ω-3 treatment group were remarkablely
lower than HS, HS/R and ω-6 group (p < 0.05), however,
they increased 4 hours although there were no differ-
ences compared with HS/R and ω-6 group, respectively.
(Figure 1C, D)
IL-6 and TNF-α in tissue
Interleukin-6 (IL-6) was measured 4 hours postresuscita-
tion because it characteristically has a later response.
Interestingly, the level of IL-6 were elevated in ω-3
group and ω-3 treatment group animals without signifi-
cant difference compared with the sham group. But the
levels of IL-6 in the other groups were elevated dramat-
ically (Table 2).
The concentration of tumor necrosis factor-α (TNF-α)
was measured 30 minutes after shock and resuscitation
because it is known to be characteristic of an earlyTable 1 Hemorrhagic shock parametersa
sham HS HS/R
Weight,(g) 232.4 ± 14.7 240.2 ± 16.4 223.3 ±
Cannulation time,(min) 20.13 ± 1.69 20.78 ± 1.40 20.60 ±
Blood removed, (ml) 5.34 ± 0.27 5.82 ± 0.23 6.15 ± 0
NS, not significant. aData are given as mean ± standard error of the mean.response to hemorrhagic shock. TNF-α was markedly el-
evated in HS, HS/R, ω-6 group and ω-3 treatment group
(Table 2). However, there was no significant difference
between the control and fish oil groups.
Lipid analysis
Levels of docosahexenoic acid (DHA) and eicosapente-
noic acid (EPA) were found to be significantly elevated
in plasma in ω-3 group and ω-3 treatment group as
compared with other groups, whereas levels of arachi-
donic acid (AA) were correspondingly reduced. The
levels of DHA and EPA in intestinal epithelial cells had
the same change trend, although there were no signifi-
cant differences in among all groups (Tables 3 and 4).
Histology
Hemorrhagic shock induced the slight intestinal inflam-
mation of the jejunum in the rats (Figure 2B), and the
intestine mucosa was destroyed after resuscitation or in-
fused by ω-6 PUFAs (Figure 2C,D). In rats, no matter
when injected fish oil, no distinguishable changes of in-
testinal histopathology were found compared with sham
rats (Figure 2E,F). On the basis of a mucosal damage
score, infusion of ω-3PUFAs was found to prevent intes-
tinal mucosal damage induced by ischemia/re-perfusion.
However, treatment of ω-6PUFAs cannot reverse the ef-
fect of ischemia/re-perfusion injury on intestinal mucosa
(Figure 2G).
Tight junctions ultrastructure
In sham animals, the tight junctions appeared as typical
membrane fusions with intact TJs structure (Figure 3A).
In contrast, TJs ultrastructure were altered after shock,
resuscitation or ω-6PUFAs infusion. Tight junctions
were discontinuous with few membrane fusions appar-
ently in colon tissues, which indicated disruption of TJs
morphology (Figure 3B-D). There were no morpho-
logical differences with the tight junctions in ω-3 group
and ω-3 treatment group compared with sham group
(Figure 3E-F).
Redistribution of occludin in epithelium
Occludin was precisely localized in the villus surface
of epithelial cells in jejunum tissues from sham rats
(Figure 4A). After shock, resuscitation or intralipid infu-
sion, the distribution of occludin was altered and theω-6 group ω-3 group ω-3 Tre P
9.43 230.67 ± 11.0 230.8 ± 8.87 240.0 ± 10.8 NS
2.07 21.63 ± 1.25 19.12 ± 1.43 22.11 ± 3.61 NS
.26 5.86 ± 0.64 6.03 ± 0.52 5.97 ± 0.49 NS
Figure 1 The levels of I-FABP and endotoxin of plasma. I-FABP in Sham group, ω-3 group and ω-3 treatment group were significantly lower
than HS,HS/R and ω-6 group (p < 0.05). The datas in 30 min and 4 hours have the same trend (A, B). The levels of endotoxin in ω-3 group and
ω-3 treatment group were dramatically increased in 30 min when compared with 4 hours (C, D).
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from ω-3 group and ω-3 treatment group had no differ-
ence compared with that of sham group.
Discussion
Hemorrhagic shock followed by resuscitation is known
to stimulate a systemic inflammatory response and intes-
tinal barrier dysfunction. Preventing the catastrophic
consequences of hemorrhagic shock remains an un-
solved problem in clinical treatment of trauma. Daily
dietary supplementation with ω-3 PUFAs has been well
established as a method to achieve an alleviation ofTable 2 Results of cytokine protein measurements (pg/mL tis
sham HS HS/R
IL-6 (4 h) 35.23 ± 6.16 91.50 ± 33.62* 122.22 ± 4
TNF-α (30 min) 30.84 ± 9.85 90.39 ± 33.76* 141.29 ± 7
*P < 0.05. Data are given as mean ± standard error of the mean.certain acute systemic inflammatory diseases such as
asthma, chronic obstructive pulmonary disease, and in-
flammatory bowel disease [10]. And there have been
numerous researches about ω-3 PUFAs in critically ill
patients [11,12]. However, clinical use of ω-3 PUFAs in
the systemic inflammatory response syndrome and intes-
tinal barrier function in hemorrhagic shock remains
lacking in evidences.
In our study, mucosal Damage Grading Score and H&E-
stained sections of jejunum indicated that ω-3 PUFAs alle-
viates morphological changes induced by ischemia and
re-perfusion. The transmission electron microscopy (TME)sue)
ω-6 group ω-3 group ω-3 Tre
1.28** 161.32 ± 19.31** 53.47 ± 25.81 71.44 ± 32.21
5.43** 126.99 ± 19.89** 56.85 ± 17.46 88.12 ± 8.09
Table 3 Fatty acids in plasma (g/L)
sham HS HS/R ω-6 group ω-3 group ω-3 Tre P
EPA (c 20:5ω-3) 0.14 ± 0.00 0.11 ± 0.05 0.10 ± 0.02 0.15 ± 0.01 18.8 ± 5.7 19.1 ± 6.5 0.01
DHA (c 22:6ω-3) 3.5 ± 1.69 2.1 ± 0.74 2.0 ± 0.89 4.5 ± 0.25 16.4 ± 4.5 20.11 ± 3.61 0.01
AA (C20:4ω-6) 10.5 ± 3.17 11.2 ± 3.23 9.1 ± 4.01 21 ± 4.61 9.20 ± 3.42 10.97 ± 5.39 0.01
Data are given as mean ± standard error of the mean. AA, arachidonic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid.
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and disruption of TJs in the mucosa. By use of immuno-
fluorescence, we demonstrated that ω-3 PUFAs could par-
tially prevent the decreased expression of occludin in
jejunum mucosa during hemorrhagic shock followed by re-
suscitation. These results are similar with other experimen-
tal results and the protective effect of fish oil attributed to
inflammation reaction alleviating and inflammation factors
reducing. Preclinical and clinical research is depicting a
therapeutic effect for consumption of the fish-oil derived in
the management of inflammatory disease in general [13].
The small intestine is highly sensitive to hypo-
perfusion injury because of higher mucosal cell oxygen
demand [14,15]. Thus, subjected to hemorrhagic shock
and resuscitation, trauma, and surgery often develop
intestinal ischemia and tissue damage, which has been
documented by both experimental [16] and clinical stud-
ies [17]. In current research, we demonstrated that the
administration of ω-3 PUFAs could partly attenuate
intestinal epithelial barrier dysfunction in hemorrhagic
shock and resuscitation rats. The levels of I-FABP in
plasma were significantly decreased after ω-3 PUFAs
administration. Our preliminary study showed the intes-
tinal barrier is severely damaged after I/R, which is
related to the redistribution of I-FABP and indicated
that n-3 PUFAs protect the intestinal barrier by modify-
ing intracellular I-FABP, activating the peroxisome
proliferator-activated receptor-γ (PPARγ) pathway, and
then upregulating TJs protein expression [18].
In the present study, we found that administration of ω-
3 PUFAs regardless of being before or during resuscitation
would reduce the systemic inflammation. The levels of IL-
6 and TNF-α in intestinal tissue of ω-3 group and ω-3
treatment group were dramatically lower than HS, HSR
and ω-6 groups’ (Table 2). This phenomenon may be
explained as the effects of ω-3 PUFAs on regulation of
host inflammatory responses. And this phenomenon isTable 4 aFatty acids in intestinal epithelial cells
sham HS HS/R
EPA (c 20:5ω-3) 2.01 ± 0.45 1.98 ± 0.12 2.10 ± 0.25
DHA (c 22:6ω-3) 2.16 ± 0.78 1.59 ± 0.44 2.50 ± 0.49
AA (C20:4ω-6) 15.3 ± 4.15 16.2 ± 3.63 17.1 ± 4.54
NS, not significant. aData are given as mean ± standard error of the mean. AA, arachassociated with the change of fatty acids in plasma and
epithelial cells (Tables 3 and 4). It is the administration
of ω-3 PUFAs that promotes the formation of eicosanoids,
which are anti-inflammatory rather than pro-inflammatory
mediators. In addition, intravenous infusion of ω-3 PUFAs
leads to decreases of prostaglandin E2, thromboxane
A2, and leukotriene B4, accompanied with increases of
thromboxane A3, prostacyclin PGI3, and leukotriene
B5. Generally, the leukotrienes, thromboxanes, and
prostaglandins derived from ω-3 PUFAs are less pro-
inflammatory than the homologus compounds derived
from ω-6 PUFAs. So, the levels of DHA and EPA signifi-
cantly elevated in plasma in ω-3 group and ω-3 treat-
ment group were the primary cause for less systemic
inflammation in the two groups. There are, however,
powerful anti-inflammatory metabolites from the ω-6
PUFAs AA, and one cannot say with validity that “ω-6
are pro-inflammatory and ω-3 are not” [19]. So we did
not find the inflammatory response becomes worse in
the rats of ω-6 group after ω-6 PUFAs infusion.
However, the levels of endotoxin in ω-3 group and ω-3
treatment group were dramatically escalated at 4 hours
after resuscitation when compared with them in 30 min.
What makes the serum endotoxin levels grow up, further-
more why the elevated endotoxin concentration did not
induce more inflammatory response and gut barrier dam-
age? Pluess et al. have domesticated that healthy volun-
teers received twice 0.5 g/kg fish oil at 48 and 24 h before
lipopolysaccharide (LPS) injected would modify the
phospholipid composition of platelets and blunted fever
and increased the neuroendocrine and the inflammatory
responses to LPS [20]. Meanwhile, in their previous study
in healthy subjects they showed that prolonged supple-
mentation with oral fish oil blunts the neuroendocrine
and inflammatory responses to LPS challenge [21]. Simi-
larly, Pittet et al. have divided male subjects into three
groups which received three different fish oil doses beforeω-6 group ω-3 group ω-3 Tre P
2.41 ± 0.51 5.47 ± 1.21 5.23 ± 1.5 NS
3.12 ± 0.75 6.45 ± 0.23 5.10 ± 1.45 NS
25 ± 5.46 17.5 ± 4.44 16.7 ± 3.72 NS
idonic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid.
Figure 2 Histological findings of the jejunum from rats (original magnification, 20 × 20). (A) Sham animals. (B) Hemorrhagic shock.
(C) Hemorrhagic shock and resuscitation. (D) Intralipid infused before resuscitation. (E) Fish oil infused before resuscitation. (F) Fish oil infused
during resuscitation. (G) Mucosal damage grading was assessed. The mean histological score of animals in HS group, HSR group and omega-6
group are significantly higher than that of sham mice, and subsequent treatment of ω-3 PUFAs could not attenuate this damage.
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before LPS was the most efficient in blunting the re-
sponses, suggesting LPS capture in addition to the sys-
temic and membrane effects. These studies may explain
the phenomenon found in our experiments, although the
concentration of endotoxin magnified, the infusion of fish
oil will blunt the inflammatory and neuroendocrine re-
sponses to alleviate the damage of gut mucosa.Conclusion
In conclusion, our data indicate—to our knowledge—
that ω-3 PUFAs can ameliorate intestinal epithelium TJ
disruption in a rat model of hemorrhagic shock followed
by resuscitation. We speculate that ω-3 PUFAs, individu-
ally or in combination with other therapy, may serve as
a potential new therapeutic agent that restores the nor-
mal intestinal barrier function in hemorrhagic shock.Materials and methods
Animals
Seventy-two male SD rats of a mean (±SD) weight of 269.26 ±
12.68 g were used and the protocol of this study was ap-
proved by the institutional animal care committee. Animals,
supplied by Medical Experiment Animal Center of Jinling
Hospital (Nanjing, China), were kept in a chamber with a
light cycle from 9 am to 9 pm and controlled temperature
of 25°C–28°C with food and water available ad libitum.
Characteristics of the study groups are presented in Table 5.Rat model of hemorrhagic shock and resuscitation
All rats were weighed and anesthetized with 60 mg/kg
ketamine intramuscular injection and then placed on a
temperature-controlled heating pads, which was heated
while shock was induced and temperature was sustained
37°C. Using aseptic techniques, the left femoral artery and
Figure 3 Tight junction morphology was altered at 4 hours after resuscitation. The intact TJ structure was observed in sham rats
(A). TJ ultrastructure was altered characterized by decreased electron dense materials in the TJ (B–D). TJ ultrastructure was integrity as sham
group (E–F). Arrows, tight junctions. Bars = 0.5 μm.
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containing 0.1 ml heparinized saline (10 units/ml) [22].
Heparin (200 U/kg) was infused immediately through
femoral vein following cannulation. The artery catheter
was connected to a multi-channel recorder (Electronics
for Medi- cine, TX) for the monitoring of systolic, dia-
stolic, and mean arterial pressures (MAP) per 3 minutes.
The target MAP (35 ~ 40 mm Hg) was induced by re-
moving blood slowly through the femoral vein cannula
during a total time of 15 minutes and maintained at 35
to 40 mm Hg with further withdrawals of blood as
required for 60 minutes. At the point of 75 minutes, re-
suscitation which would take 30 minutes was imple-
mented by returning half of the shed blood and Ringer’s
solution to the animal at the speed of 0.5 mL/min. And
Infusion was withheld if MAP exceeded 90% of baseline
and re-started if declined. At the 105th minute, resusci-
tation was finished and no interventions were carried
out. The rats in ω-6 group and ω-3 group were injected
by intralipid and fish oil (Omegaven, Huarui Pharma-
ceutical Co., Ltd. 0.2 g/Kg) respectively through the
caudal vena after shock 30 min. And the rats in ω-3
treatment group were injected by fish oil (0.2 g/Kg)during resuscitation. At the end of 30 minutes of resus-
citation, half of the animals of these three groups were
randomly sacrificed to collect blood samples, and the
others were killed at the end of 4 hours. The 2–3 ml
sample was centrifuged at 4°C. After centrifugation,
serum was kept refrigerated at -80°C until assayed.
Measurement of I-FABP and endotoxin in plasma
The blood sample was centrifuged at 10 000 × g for
15 min at 4°C. The supernatant was assayed for I-FABP
and endotoxin levels by enzyme-linked immunosorbent
assay kits (R&D Systems, Minneapolis, MN, USA) in ac-
cordance with the manufacturer’s instructions. The ab-
sorbance at 450 nm was determined using a microplate
reader (Tecan’s, Sunrise, Unterberg strasse IA, Austria).
Measurement of IL-6 and TNF-α in tissue
The jejunum at 2 cm beyond Treitz ligament was
weighed and homogenized by adding 9 times gravimetric
saline. The 10% homogenate was centrifuged for 10 mi-
nutes (2500 r/min) and the supernatant was diluted 10
times with normal saline to 1% concentration. The 1%
supernatant was assayed for IL-6 and TNF-a levels by
Figure 4 Redistribution of occludin in hemorrhagic shock rats. Occludin (A, E, F) was precisely localized to the tight junction in the jejunum
from sham group, ω-3 group and ω-3 treatment group. In contrast, the jejunum from shock, resuscitation and ω-6 group showed redistribution
of occludin (B, C, D). Bars = 25 mm.
Li et al. Lipids in Health and Disease 2014, 13:146 Page 7 of 9
http://www.lipidworld.com/content/13/1/146enzyme-linked immunosorbent assay kits (R&D Systems,
Minneapolis, MN, USA) in accordance with the manu-
facturer’s instructions.
Fatty acid analysised
To verify that the treatments change resulted in the in-
corporation of significant amounts of DHA and EPA into
membrane lipids and plasma, fatty acid analysised was car-
ried out in intestinal epithelial cells and plasma. SmallTable 5 Characteristics of study groups
SHAM (n = 12) control (cannulation and Heparinized)
HS (n = 12) control + shock
HS/R (n = 12) HS + fluid resuscitation
ω-6 group (n = 12) HS/R + intralipid (0.2 g/kg) intravenous
after shock 30 min
ω-3 group (n = 12) HS/R + fish oil (0.2 g/kg) intravenous
after shock 30 min
ω-3 treatment group (n = 12) HS/R + fish oil (0.2 g/kg) intravenous
during resuscitation
HS, hemorrhagic shock; HS/R, hemorrhagic shock and resuscitation.intestine samples were first homogenized and the cell pel-
let isolated by centrifugation and frozen until analysis.
Total small intestine lipids were extracted with methanol
and methylene (both containing 50 mg/L BHT) as de-
scribed [23]. The organic phase was collected and the
solvent evaporated under nitrogen in a 45°C water bath.
The samples were methylated as described [24]. The sam-
ples were analyzed by gas chromatography (GC-14A;Table 6 Intestinal mucosal damage grading score
Grade Histological characteristic(s)
Grade 0 Normal mucosal villi
Grade 1 Subepithelial Gruenhagen’s space (oedema),
usually at the apex of the villus
Grade 2 Extension of the subepithelial space with moderate
lifting of epithelial layer from the lamina propria
Grade 3 Massive epithelial lifting down the sides of villi;
a few tips may be denuded
Grade 4 Denuded villi with lamina propria and dilated
capillaries exposed
Grade 5 Digestion and disintegration of lamina propria;
haemorrhage and ulceration
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column (SP-2560, 100 m; Supelco, Bellefonte, PA). Fatty
acid methyl esters are reported as percent of total and
were identified by comparison with known standards.
DHA and EPA in plasma were quantified by one-step
rapid extractive methylation for gas chromatographic
analysis [25], as described previously [26,27]. First, cit-
rate plasma was spiked with heptadecanoic acid as in-
ternal standard. Next, free fatty acids were converted to
methyl esters by mixing with ethereal diazomethane. Lastly,
the ethereal layer was dried, redissolved in chloroform, and
transferred to the gas chromatograph. The fatty acid me-
thyl esters were detected by use of a flame ionization de-
tector, and peak area integration was performed.
Histopathological evaluation
The proximal jejunum specimens were harvested imme-
diately after the animals were sacrificed, and rinsed in
cold saline with subsequent immersion in 10% buffered
formalin over- night at room temperature. Sections
measuring 5-μm in thickness were cut down, placed on
glass slides, and stained with hematoxylin and eosin
(H&E). Images were obtained using a Zeiss Image A1
light microscope at × 20 magnification with AxioVision
V4.5 software. Three pathologists, blinded to the source
of the slides, analyzed and made a report about every
slide. The degree of histopathologic changes was graded
semiquantitatively by using the histologic injury score
described by Chiu et al. [28] (Table 6).
Transmission electron microscopy (TEM)
Two-millimeter sections of colon were fixed for 2 h in
4% buffered glutaraldehyde. The sections were cut into
smaller pieces, then fixed by 1% OsO4, sequentially
dehydrated through graded alcohols, infiltrated through
Epon 812 and then embedded in resin. Thin sections
were cut and stained with uranyl acetate and lead citrate,
and examined with a Hitachi H-600 (Tokyo, Japan)
transmission electron microscope operated at 75 kV.
Laser scanning confocal microscopy (LSCM)
Immunofluorescence staining of the proximal jejunum
tissues was performed according to the method de-
scribed by Guttman et al. [29]. After being rinsed with
ice-cold PBS, tissues were fixed in 3% paraformaldehyde,
embedded in an optimal cutting temperature compound
(OCT; Sakura Finetech, USA) and 6 mm thick serial sec-
tions were cut. Tissue sections were treated with 0.2%
Triton X- 100 in phosphate-buffered saline (PBS) for
20 min and then blocked with 5% normal goat serum in
PBS containing 0.05% Tween-20 and 0.1% bovine serum
albumin. Tissues were incubated with monoclonal anti-
bodies against occludin or ZO-1 (1:200) in PBS with 1%
goat serum overnight at 4°C. After washing, sectionswere incubated with Alexa 488-conjugated secondary
antibodies for 60 min. DAPI was used for staining DNA
of cells. Images were captured using a Leica TCS SP2
laser confocal scanning microscope (Leica Micro- sys-
tems, Heidelberg GmbH, Mannheim, Germany).
Statistical analysis
Data results are presented as mean ± standard error.
Comparisons of various hemorrhagic shock parameters,
I-FABP, endotoxin, oxidative and inflammatory mole-
cules, blood, and histological score between the four
groups were performed by ANOVA test. A significance
level of .05 was used for all analyses.
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